HSCT FOR CHRONIC MYELOPROLIFERATIVE DISEASES: Primary myelofibrosis, polycythemia vera, essential thrombocythemia

Vaneuza Araújo Moreira Funke; Marcos Paulo Colella; Antonio Vaz de Macedo; Gustavo Machado Teixeira; Andreza Alice Feitosa Ribeiro; Afonso Celso Vigorito

doi:10.46765/2675-374X.2021v4n1p89-100

HSCT FOR CHRONIC MYELOPROLIFERATIVE DISEASES

Primary myelofibrosis, polycythemia vera, essential thrombocythemia

Authors

Vaneuza Araújo Moreira Funke
Marcos Paulo Colella
Antonio Vaz de Macedo
Gustavo Machado Teixeira
Andreza Alice Feitosa Ribeiro
Afonso Celso Vigorito

DOI:

https://doi.org/10.46765/2675-374X.2021v4n1p89-100

Abstract

THE BRAZILIAN SOCIETY FOR BLOOD AND MARROW TRANSPLANTATION (SBTMO) PRESENTS THE BRAZILIAN GUIDELINES ON HEMATOPOIETIC STEM CELL TRANSPLANTATION

Downloads

Published

03/11/2021

How to Cite

Funke, V. A. M., Colella, M. P., Macedo, A. V. de, Teixeira, G. M., Ribeiro, A. A. F., & Vigorito, A. C. (2021). HSCT FOR CHRONIC MYELOPROLIFERATIVE DISEASES: Primary myelofibrosis, polycythemia vera, essential thrombocythemia. JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2(1), 89–100. https://doi.org/10.46765/2675-374X.2021v4n1p89-100